University of Sao Paulo Clinical Trials
Sponsors / University of Sao Paulo
University of Sao Paulo is listed as the lead sponsor on 654 clinical trials registered with ClinicalTrials.gov. Across the portfolio, 28 are in recruitment, 8 are active non-recruiting, and 399 have reached completion. 16 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Across the portfolio, planned enrollment totals 77,087 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
654
Total Trials
28
Recruiting
8
Other Active
399
Completed
16
Terminated / Withdrawn
77,087
Total Enrollment
Termination reasons: Other69% · Recruitment13% · Efficacy13% · Funding6%
Recent Terminations
- Endometriosis"The study was prematurely terminated due to the results of the interim analysis conducted, as outlined in the initial project plan."
- Treatment Side Effects
- Angiotensin II Receptor Antagonist Adverse Reaction"Dificulteis in enrolling patients"
- Diabetes Mellitus, Type 1"COVID-19 pandemics"
- Trigeminal Neuralgia"Study halted due to futility"
- Cardiovascular Diseases
- Subfertility"The main investigators are no longer working at the center."
- Cystic Fibrosis"It was impossible for us to include patients"
- Bronchiolitis"Technical difficulties (reduced staff plus university strike)"
- NCT01839136 Phase NAInfertility"Low pregnancy rates in both groups"
Active Trials (8 total)
- NCT06716489
- NCT07466069
- Halitosis NANCT07463859
- NCT06922812
- NCT07429578
- Funnel Chest NANCT07431632
- NCT07381972
- NCT07317206
- NCT07317219
- NCT07317232
- NCT07289919
- Episiotomy NANCT07170007
- NCT07149519
- NCT07150052
- NCT05194137
- NCT07007377
- Central Neuropathic Pain PHASE1NCT06978764
- Acute Coronary Syndrome PHASE2/PHASE3NCT06286878
- NCT06861582
- NCT04447807